Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Alerts

Watch

Help

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Oct 4, 3:05PM CDT

CMTX - Fri Oct 4, 3:05PM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on October 1, 2019, the independent Compensation...

Patients Turn to Assistance Programs for Aid in the Fight Against Chronic Diseases PR Newswire Europe - Fri Oct 4, 8:02AM CDT

CMTX - Fri Oct 4, 8:02AM CDT

With the advancement of the cancer therapy market, new forms of treatment are now being studied and manufactured. Additionally, demand is expected to keep growing for currently effective treatments. Not...

Curis to Present at Cantor Fitzgerald Global Healthcare Conference PR Newswire - Thu Sep 26, 7:00AM CDT

CMTX - Thu Sep 26, 7:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, Chief Executive Officer of Curis,...

Curis Announces Promotion of Bill Steinkrauss to Chief Financial Officer PR Newswire - Thu Sep 12, 7:00AM CDT

CMTX - Thu Sep 12, 7:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the promotion of Bill Steinkrauss to Chief Financial...

Curis Hires Industry Veterans to Lead Clinical Development and Regulatory Affairs PR Newswire - Tue Aug 13, 7:00AM CDT

CMTX - Tue Aug 13, 7:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the appointment of Reinhard von Roemeling, M.D., as...

Curis: 2Q Earnings Snapshot APAI - Tue Aug 6, 4:23PM CDT

APAI - Tue Aug 6, 4:23PM CDT

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $7.2 million in its second quarter.

Curis Reports Second Quarter 2019 Financial Results PR Newswire - Tue Aug 6, 3:01PM CDT

CMTX - Tue Aug 6, 3:01PM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the second quarter ended...

Curis to Release Second Quarter Financial Results and Hold Conference Call on August 6, 2019 PR Newswire - Tue Jul 30, 7:00AM CDT

CMTX - Tue Jul 30, 7:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its second quarter financial...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Jul 5, 3:01PM CDT

CMTX - Fri Jul 5, 3:01PM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on July 1, 2019, the independent Compensation...

Curis: 1Q Earnings Snapshot APAI - Tue May 14, 3:29PM CDT

APAI - Tue May 14, 3:29PM CDT

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $9.9 million in its first quarter.

Curis Reports First Quarter 2019 Financial Results PR Newswire - Tue May 14, 3:05PM CDT

CMTX - Tue May 14, 3:05PM CDT

Curis to Release First Quarter Financial Results and Hold Conference Call on May 14, 2019 PR Newswire - Tue May 7, 7:00AM CDT

CMTX - Tue May 7, 7:00AM CDT

Curis Completes Mesothelioma Enrollment in CA-170 Study PR Newswire - Mon May 6, 7:00AM CDT

CMTX - Mon May 6, 7:00AM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Phase 1 study of CA-170 has reached its target...

Healthcare Companies Search for New Ways to Oppose the Spread of Cancer CNW Group - Wed Apr 17, 8:00AM CDT

CMTX - Wed Apr 17, 8:00AM CDT

Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...

Research Report Identifies Denison Mine, Obsidian Energy, Cherry Hill Mortgage Investment, Curis, DASAN Zhone Solutions, and CVD Equipment with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement GlobeNewswire - Fri Apr 12, 8:00AM CDT

CMTX - Fri Apr 12, 8:00AM CDT

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Denison Mine Corp (NYSE:DNN), Obsidian...

Curis Regains Compliance with Nasdaq Continued Listing Requirements PR Newswire - Wed Apr 10, 7:00AM CDT

CMTX - Wed Apr 10, 7:00AM CDT

Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced today that it received written confirmation from the Listing...

Curis Announces Advancement to the 200mg BID Cohort in the CA-4948 Study PR Newswire - Mon Apr 8, 7:00AM CDT

CMTX - Mon Apr 8, 7:00AM CDT

Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced today that it has begun dosing patients in the 5th cohort...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Fri Apr 5, 3:30PM CDT

CMTX - Fri Apr 5, 3:30PM CDT

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 2, 2019, the independent Compensation...

Curis: 4Q Earnings Snapshot APAI - Tue Mar 26, 3:17PM CDT

APAI - Tue Mar 26, 3:17PM CDT

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $5.9 million in its fourth quarter.

Curis Reports Fourth Quarter and Year-End 2018 Financial Results PR Newswire - Tue Mar 26, 3:00PM CDT

CMTX - Tue Mar 26, 3:00PM CDT

Van Meerten Stock Picks

The 5 Best Large Caps

I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.

Mon Aug 19, 3:14PM CDT

CCI -1.54 , AIZ +0.24 , SBAC -1.35 , SO -0.28 , WELL -0.42

Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

MAIN MENU

POPULAR

quotes

charts

technicals

options

company

analysts

financials

Curis Inc (CRIS)

Curis Inc (CRIS)

Van Meerten Stock Picks

InsideFutures Commentary

Want to use this as
your default charts setting?

Switch the Market flag
above for targeted data.

Open the menu and switch the
Market flag for targeted data.

Get Streaming Chart Updates

Need More Chart Options?

Free Barchart Webinar

MAIN MENU

POPULAR

quotes

charts

technicals

options

company

analysts

financials

Curis Inc (CRIS)

Curis Inc (CRIS)

Van Meerten Stock Picks

InsideFutures Commentary

Want to use this as your default charts setting?

Switch the Market flag above for targeted data.

Open the menu and switch the Market flag for targeted data.

Get Streaming Chart Updates

Need More Chart Options?

Free Barchart Webinar

Want to use this as
your default charts setting?

Switch the Market flag
above for targeted data.

Open the menu and switch the
Market flag for targeted data.